Advertisement

Topics

BRIEF—FDA approves Vraylar as schizophrenia maintenance therapy

11:26 EST 13 Nov 2017 | thePharmaLetter

The Food and Drug Administration has approved the supplemental New Drug Application (sNDA) submitted…

Original Article: BRIEF—FDA approves Vraylar as schizophrenia maintenance therapy

NEXT ARTICLE

More From BioPortfolio on "BRIEF—FDA approves Vraylar as schizophrenia maintenance therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...